Press Releases 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals to Present at the William Blair 42nd Annual Growth Stock Conference 5/26/22 Eagle Pharmaceuticals Reports First Quarter 2022 Results 5/9/22 Eagle Pharmaceuticals to Host First Quarter 2022 Financial Results on May 9, 2022 4/28/22 Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028 4/19/22 Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc 3/28/22 Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results 3/7/22 Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022 2/24/22 Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™ 2/1/22 Eagle Pharmaceuticals on Track to Support Submission of New Drug Application in Second Quarter 2022 for Landiolol, a Beta-1 Adrenergic Blocker 1/31/22 Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin 1/18/22 Pagination First page Previous page Page 1 Current page 2 Page 3 Next page Last page
